Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,503 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia.
Ahrén B, Holst JJ. Ahrén B, et al. Among authors: holst jj. Diabetes. 2001 May;50(5):1030-8. doi: 10.2337/diabetes.50.5.1030. Diabetes. 2001. PMID: 11334405
Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.
Gutniak M, Orskov C, Holst JJ, Ahrén B, Efendic S. Gutniak M, et al. Among authors: holst jj. N Engl J Med. 1992 May 14;326(20):1316-22. doi: 10.1056/NEJM199205143262003. N Engl J Med. 1992. PMID: 1348845
Discussing the role of glucagonlike peptide-I.
Holst JJ, Orskov C. Holst JJ, et al. Diabetes Care. 1992 Oct;15(10):1440-1. doi: 10.2337/diacare.15.10.1440. Diabetes Care. 1992. PMID: 1425120 No abstract available.
Glucagon immunoneutralization in diabetic rats normalizes urea synthesis and decreases nitrogen wasting.
Almdal TP, Holst JJ, Heindorff H, Vilstrup H. Almdal TP, et al. Among authors: holst jj. Diabetes. 1992 Jan;41(1):12-6. doi: 10.2337/diab.41.1.12. Diabetes. 1992. PMID: 1727732
Heterogeneity of immunoreactive gastric inhibitory polypeptide in the plasma of newly diagnosed type 1 (insulin-dependent) diabetics.
Krarup T, Holst JJ, Madsbad S. Krarup T, et al. Among authors: holst jj. Acta Endocrinol (Copenh). 1987 Jan;114(1):74-83. doi: 10.1530/acta.0.1140074. Acta Endocrinol (Copenh). 1987. PMID: 3544634
Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type I (insulin-dependent) diabetics.
Krarup T, Madsbad S, Moody AJ, Regeur L, Faber OK, Holst JJ, Sestoft L. Krarup T, et al. Among authors: holst jj. J Clin Endocrinol Metab. 1983 Jun;56(6):1306-12. doi: 10.1210/jcem-56-6-1306. J Clin Endocrinol Metab. 1983. PMID: 6341393
Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects.
Deacon CF, Nauck MA, Toft-Nielsen M, Pridal L, Willms B, Holst JJ. Deacon CF, et al. Among authors: holst jj. Diabetes. 1995 Sep;44(9):1126-31. doi: 10.2337/diab.44.9.1126. Diabetes. 1995. PMID: 7657039
Subcutaneous injection of the incretin hormone glucagon-like peptide 1 abolishes postprandial glycemia in NIDDM.
Gutniak MK, Linde B, Holst JJ, Efendić S. Gutniak MK, et al. Among authors: holst jj. Diabetes Care. 1994 Sep;17(9):1039-44. doi: 10.2337/diacare.17.9.1039. Diabetes Care. 1994. PMID: 7988303 Clinical Trial.
Resistant starch: the effect on postprandial glycemia, hormonal response, and satiety.
Raben A, Tagliabue A, Christensen NJ, Madsen J, Holst JJ, Astrup A. Raben A, et al. Among authors: holst jj. Am J Clin Nutr. 1994 Oct;60(4):544-51. doi: 10.1093/ajcn/60.4.544. Am J Clin Nutr. 1994. PMID: 8092089 Clinical Trial.
Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans.
Orskov C, Rabenhøj L, Wettergren A, Kofod H, Holst JJ. Orskov C, et al. Among authors: holst jj. Diabetes. 1994 Apr;43(4):535-9. doi: 10.2337/diab.43.4.535. Diabetes. 1994. PMID: 8138058
1,503 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback